Centre Hospitalier des Pays de Morlaix
6
3
3
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Validation of the French Version of the QASCI in Caregivers of Patients With COPD
Role: collaborator
Telerehabilitation Versus Centre-based Pulmonary Rehabilitaztion for Patients With Chronic Obstructive Pulmonary Disease
Role: collaborator
Accidentology and Traumatology Associated With Foiling in Brittany
Role: collaborator
Effects of Chest Physiotherapy in Hyperventilation Syndrome
Role: lead
Study Among People Living With HIV and Their Health Professionals of Associated Factors of Resilience to Self-stigma
Role: collaborator
Comparison of 3-Minute Step Test (3MStepT) and 6-Minute Walk Test (6MWT) in COPD Patients
Role: lead
All 6 trials loaded